Effect of auricular vagus nerve stimulation by electroacupuncture on upper limb motor function in patients with ischemic stroke

注册号:

Registration number:

ITMCTR2100004613

最近更新日期:

Date of Last Refreshed on:

2021-03-23

注册时间:

Date of Registration:

2021-03-23

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

电针耳穴迷走神经刺激对脑梗死偏瘫患者上肢运动功能的影响

Public title:

Effect of auricular vagus nerve stimulation by electroacupuncture on upper limb motor function in patients with ischemic stroke

注册题目简写:

English Acronym:

研究课题的正式科学名称:

电针耳穴迷走神经刺激对脑梗死偏瘫患者上肢运动功能的影响

Scientific title:

Effect of auricular vagus nerve stimulation by electroacupuncture on upper limb motor function in patients with ischemic stroke

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

重庆市科卫联合中医药技术创新与应用发展项目(2021ZY023818)

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100044500 ; ChiMCTR2100004613

申请注册联系人:

刘依林

研究负责人:

贾功伟

Applicant:

Yilin Liu

Study leader:

Gongwei Jia

申请注册联系人电话:

Applicant telephone:

+86 15282843369

研究负责人电话:

Study leader's telephone:

+86 023-63693075

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yilin646@163.com

研究负责人电子邮件:

Study leader's E-mail:

jiagongwei@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区临江路74号

研究负责人通讯地址:

重庆市渝中区临江路74号

Applicant address:

74 Linjiang Road, Yuzhong District, Chongqing, China

Study leader's address:

74 Linjiang Road, Yuzhong District, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆医科大学附属第二医院

Applicant's institution:

The Second Affiliated Hospital of Chongqing Medical University

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

(2020) 216

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

重庆医科大学附属第二医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

1990/1/1 0:00:00

伦理委员会联系人:

吴明珍

Contact Name of the ethic committee:

Mingzhen Wu

伦理委员会联系地址:

重庆市渝中区临江路74号

Contact Address of the ethic committee:

74 Linjiang Road, Yuzhong District, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属第二医院

Primary sponsor:

The Second Affiliated Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区临江路74号

Primary sponsor's address:

74 Linjiang Road, Yuzhong District, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第二医院

具体地址:

渝中区临江路74号

Institution
hospital:

The Second Affiliated Hospital of Chongqing Medical University

Address:

74 Linjiang Road, Yuzhong District

经费或物资来源:

重庆市科卫联合中医药技术创新与应用发展项目(2021ZY023818)

Source(s) of funding:

Chongqing Science Committee and Health Committee Joint Traditional Chinese Medicine Technology Innovation and Application Development Project(2021ZY023818)

研究疾病:

脑梗死

研究疾病代码:

Target disease:

ischemic stroke

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

电针耳穴迷走神经刺激促进脑梗死后遗症期偏瘫患者上肢运动功能恢复作用的安全性、有效性。

Objectives of Study:

To investigate the safety and effectiveness of auricular vagus nerve stimulation by electroacupuncture on upper limb function in patients with sequelae of ischemic stroke.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①首次发病且病程>6月。 ②诊断符合全国第四届脑血管病学术会议修订的诊断标准并经头颅CT或MRI证实。 ②既往肢体活动正常,目前存在不同程度的偏瘫。 ④生命体征平稳,无意识障碍。 ⑤能够遵医嘱服用脑梗死二级预防药物及配合常规康复训练的患者。 ⑥同意参与本试验者。

Inclusion criteria

1.Cerebral infarction with a first onset and onset more than 6 months; 2.The diagnosis was in accordance with the revised diagnostic criteria of the Fourth National Conference on Cerebrovascular Diseases and confirmed by head CT or MRI; 3.The previous physical activity was normal, and there were different degrees of hemiplegia in admission; 4.Vital signs are stable and unconscious; 5.can take the secondary prevention drugs for cerebral infarction and patients with routine rehabilitation training; 6.agree to participate in the trial.

排除标准:

①出血性脑梗死、腔隙性脑梗死。 ②严重的心、肺、肝、肾功能不全及血液系统疾病。 ③恶性肿瘤或各种感染性疾病。 ④存在骨关节系统等疾病影响肌力评定的患者。 ⑤无法配合康复评定的患者。

Exclusion criteria:

1.Hemorrhagic cerebral infarction, lacunar infarction; 2.severe heart, lung, liver, kidney dysfunction and blood system diseases; 3.malignant tumors or various infectious diseases; 4.Patients with bone and joint system and other diseases affect muscle strength assessment; 5.Patients who cannot be combined with rehabilitation assessment.

研究实施时间:

Study execute time:

From 2021-03-23

To      2022-06-23

征募观察对象时间:

Recruiting time:

From 2021-03-23

To      2021-06-23

干预措施:

Interventions:

组别:

常规治疗组

样本量:

40

Group:

Group 2

Sample size:

干预措施:

常规治疗

干预措施代码:

Intervention:

Conventional rehabilitation training

Intervention code:

组别:

电针耳穴刺激迷走神经组

样本量:

40

Group:

Group 1

Sample size:

干预措施:

电针耳穴刺激迷走神经

干预措施代码:

Intervention:

auricular vagus nerve stimulation by electroacupuncture

Intervention code:

样本总量 Total sample size : 80

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第二医院

单位级别:

三级甲等

Institution/hospital:

The Second Affiliated Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

上肢Fugl-Meyer评定(the upper extremity Fugl-Meyer,UEFM)评分增加值≥5的受试者比例

指标类型:

主要指标

Outcome:

Proportion of subjects whose upper extremity Fugl-Meyer score increased ≥5

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Wolf运动功能测试

指标类型:

次要指标

Outcome:

Wolf motor function test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

上肢动作研究测试量表

指标类型:

次要指标

Outcome:

Action Research Arm Test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

主动腕背伸活动度

指标类型:

次要指标

Outcome:

active range of motion

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Barthel指数变化值

指标类型:

次要指标

Outcome:

Barthel index change value

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

上肢 Fugl-Meyer变化的绝对值

指标类型:

次要指标

Outcome:

the absolute value of the upper extremity Fugl-Meyer change

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小
Min age years
最大
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table

盲法:

盲评价者,盲统计者

Blinding:

outcome assessors and statisticians were blinded to group allocation

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

文章发表 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not stated

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above